This is a knockout-validated antibody summary, based on the publication "Kinesin-1 controls mast cell degranulation and anaphylaxis through PI3K-dependent recruitment to the granular Slp3/Rab27b complex", as cited below [1]. This clone was also validated for Western blot in the article "A small-molecule activator of kinesin-1 drives remodeling of the microtubule network" (see figure 3c) [2]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Mouse IgG1
Company: BioLegend / DSHB
Antibody: Kif5b
Catalog number: SUK 4
Summary: This product is discontinued from BioLegend. The same clone is available from DSHB.
Note: The clone name is SUK 4.
Immunocytochemistry
WT and Kif5b-cKO bone marrow–derived mast cells (BMMCs).
ICC: in permeabilization buffer (PBS with 1 mg/ml bovine serum albumin and 0.05% wt/vol saponin; Sigma-Aldrich) for 1 h.
ICC: fluorescent-conjugated secondary antibody in permeabilization buffer for 1 hour
ICC: Confocal microscopy was performed with an LSM 700 system (ZEISS) and 63× NA 1.4 objective.
- Munoz I, Danelli L, Claver J, Goudin N, Kurowska M, Madera-Salcedo I, et al. Kinesin-1 controls mast cell degranulation and anaphylaxis through PI3K-dependent recruitment to the granular Slp3/Rab27b complex. J Cell Biol. 2016;215:203-216 pubmed
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.